CYTEIR THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 May 2023)
What this means for you
This application is over — abandoned 22 May 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88510194
- Mark type
- Design + words
- Filed
- 11 Jul 2019
- Published for opposition
- 25 Feb 2020
- Abandoned
- 22 May 2023
- Attorney of record
- Karen Won
Goods and services
- Class 042 — Scientific and technological services: Research and development of medical tests for analyzing synthetic lethality and DNA damage; research and development of synthetic lethal therapies and biomarkers of synthetic lethality; medical laboratory services; medical testing for scientific research purposes in the field of oncology, synthetic lethality, and DNA repair; providing medical and scientific research information in the fields of synthetic lethality, DNA repair, synthetic lethal therapies, oncology, hematology, and immunology; drug discovery services
- Class 044 — Medical, beauty and agricultural services: Medical testing for diagnostic or treatment services; medical testing services for developing personalized therapies
Owner
- Cyteir Therapeutics, Inc., Lexington, MA, US
- Cyteir Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 22 May 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 May 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Oct 2022 — SOU EXTENSION 5 GRANTED
- 13 Oct 2022 — SOU EXTENSION 5 FILED
- 13 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2022 — SOU EXTENSION 4 GRANTED
- 20 Apr 2022 — SOU EXTENSION 4 FILED
- 20 Apr 2022 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Sept 2021 — SOU EXTENSION 3 GRANTED
- 08 Sept 2021 — SOU EXTENSION 3 FILED
- 08 Sept 2021 — SOU TEAS EXTENSION RECEIVED
- 16 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED